ASX
Clarity Pharmaceuticals Ltd
CU6:ASX•Healthcare
Sensitive ASX Announcement
IND Approval by US FDA for Phase II SAR-Bombesin trial
Published: 06/06/22, 09:31am (AEST)•3 pages